Totals
- Total revenue
- $623,604
- Total expenses
- $1,125,752
- Contributions and grants received
- $559,168
- Grants paid
- $0
- Program service revenue
- $0
- Investment income
- $42,761
- Other revenue
- $21,675
- Total assets, end of year
- $1,321,299
- Total liabilities, end of year
- $249,084
- Net assets or fund balances, end of year
- $1,072,215
- Program services expenses (Part IX)
- $344,237
- Management and general expenses
- $289,748
- Fundraising expenses
- $491,767
- Program service expenses (Part III)
- $344,237
Program services were 30.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$59,168
-
1f · All other contributions, gifts and grants
$500,000
-
1g · Noncash contributions included above
$59,168
-
3 · Investment income
total $42,761 · excluded $42,761
-
11a · Other revenue: REIMBURSEMENTS
total $21,675 · excluded $21,675
-
11e · Other revenue, total
$21,675
Functional expenses
Part IX, the statement of functional expenses.
-
11b · Fees: legal
total $21,210 · management and general $21,210
-
11c · Fees: accounting
total $74,670 · management and general $74,670
-
11g · Fees: other
total $905,230 · program services $316,831 · management and general $135,784 · fundraising $452,615
-
13 · Office expenses
total $366 · program services $128 · management and general $55 · fundraising $183
-
14 · Information technology
total $14,158 · program services $4,955 · management and general $2,124 · fundraising $7,079
-
16 · Occupancy
total $28,187 · management and general $28,187
-
17 · Travel
total $63,780 · program services $22,323 · management and general $9,567 · fundraising $31,890
-
24a · Other expenses: MISCELLANEOUS
total $18,151 · management and general $18,151
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $11,005 · end of year $21,495
-
2 · Savings and temporary cash investments
beginning of year $1,657,566 · end of year $1,294,120
-
9 · Prepaid expenses and deferred charges
end of year $5,684
-
17 · Accounts payable and accrued expenses
beginning of year $94,208 · end of year $249,084
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $1,574,363 · end of year $1,072,215
Mission and programs · 2024
Mission
THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE (READDI) IS A NONPROFIT BIOTECHNOLOGY ORGANIZATION DEDICATED TO PREVENTING GLOBAL CATASTROPHES CAUSED BY VIRUSES AND A LEADER IN THE THERAPEUTICS PILLAR OF THE 3-PRONGED PANDEMIC PREPAREDNESS AND RESPONSE STRUCTURE OF IPPS.
Activities or mission (Part I)
THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE (READDI) IS A NONPROFIT BIOTECHNOLOGY ORGANIZATION DEDICATED TO PREVENTING GLOBAL CATASTROPHES CAUSED BY VIRUSES. IT PLAYS A CLEAR, SPECIFIC AND CENTRAL ROLE IN THE WIDELY ACCEPTED THREE-PRONGED PANDEMIC PREPAREDNESS APPROACH INVOLVING DIAGNOSTICS, THERAPEUTICS AND VACCINES. READDI DEVELOPS THERAPEUTICS.
-
- READDI'S STANDING HAS RISEN IN THE GLOBAL PANDEMIC PREPAREDNESS COMMUNITY BY LEADING A NEWLY FORMED THERAPEUTICS DEVELOPMENT COALITION. READDI IS COLLABORATING WITH THE INTERNATIONAL PANDEMIC PREPAREDNESS COALITION, UNITAID, DRUGS FOR NEGLECTED DISEASES (DNDI) AND THE INTREPID ALLIANCE TO COORDINATE AND ACCELERATE THE DISCOVERY AND DEVELOPMENT OF ANTIVIRAL THERAPEUTICS FOR ACUTE AND ENDEMIC VIRAL DISEASES THAT HAVE THE POTENTIAL TO BECOME PANDEMICS.- IN CONJUNCTION WITH THE THERAPEUTICS DEVELOPMENT COALITION, READDI IS FOSTERING RELATIONSHIPS WITH GLOBAL HEALTHCARE LEADERS INTERESTED IN SUPPORTING DEVELOPMENT OF THERAPEUTICS FOR INFECTIOUS DISEASES.- READDI AUTHORED OR CO-AUTHORED SEVERAL PUBLISHED ARTICLES ON THE NECESSITY OF ANTIVIRAL DRUG DEVELOPMENT THAT WERE WELL RECEIVED BY THE GLOBAL COMMUNITY.- READDI'S GLOBAL NETWORK OF COLLABORATORS HAS GROWN FROM APPROXIMATELY 30 INSTITUTIONS TO APPROXIMATELY 65. - READDI'S POTENTIAL PIPELINE OF DRUG HITS, LEADS AND CANDIDATES HAS GROWN TO APPROXIMATELY 30 ACTIVE PROJECTS THAT WE ARE CLOSELY MONITORING FOR IN-LICENSING OPPORTUNITIES.
Expenses $344,237
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
John BamforthJOHN BAMFORTH
BOARD MEMBER
- Total calculated
- $448,540
- From this org
- $0
- From related orgs
- $400,121
- Other
- $48,419
- Hours/week
- 0.5 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $399,281 related
- Bonus
- $0
- Other
- $0 + $840 related
- Deferred
- $0 + $48,419 related
- Nontaxable benefits
- $0
- Filer's total
- $0 + $448,540 related
-
Richard BurrRICHARD BURR
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
J Christopher ClemensJ CHRISTOPHER CLEMENS
BOARD MEMBER THRU 6/10/25
- Total calculated
- $604,650
- From this org
- $0
- From related orgs
- $538,746
- Other
- $65,904
- Hours/week
- 0.5 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $497,156 related
- Bonus
- $0
- Other
- $0 + $41,590 related
- Deferred
- $0 + $48,499 related
- Nontaxable benefits
- $0 + $17,405 related
- Filer's total
- $0 + $604,650 related
-
Laurent FraisseLAURENT FRAISSE
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.3
-
Andy JohnsANDY JOHNS
BOARD MEMBER
- Total calculated
- $443,422
- From this org
- $0
- From related orgs
- $338,459
- Other
- $104,963
- Hours/week
- 0.5 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $337,619 related
- Bonus
- $0
- Other
- $0 + $840 related
- Deferred
- $0 + $84,639 related
- Nontaxable benefits
- $0 + $20,324 related
- Filer's total
- $0 + $443,422 related
-
Perrin JonesPERRIN JONES
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.3
-
Nathan KnuffmanNATHAN KNUFFMAN
BOARD MEMBER
- Total calculated
- $568,710
- From this org
- $0
- From related orgs
- $433,022
- Other
- $135,688
- Hours/week
- 0.4 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $422,664 related
- Bonus
- $0
- Other
- $0 + $10,358 related
- Deferred
- $0 + $127,003 related
- Nontaxable benefits
- $0 + $8,685 related
- Filer's total
- $0 + $568,710 related
-
Lydia OgdenLYDIA OGDEN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Tom ShanahanTOM SHANAHAN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.4
-
Barbara StephensonBARBARA STEPHENSON
BOARD MEMBER
- Total calculated
- $411,327
- From this org
- $0
- From related orgs
- $330,747
- Other
- $80,580
- Hours/week
- 0.5 + 40 related
Schedule J breakdown matched by us
- Base
- $0 + $326,757 related
- Bonus
- $0
- Other
- $0 + $3,990 related
- Deferred
- $0 + $80,484 related
- Nontaxable benefits
- $0 + $96 related
- Filer's total
- $0 + $411,327 related
-
Brad WilkenBRAD WILKEN
BOARD MEMBER THRU 6/10/25
- Total calculated
- $0
- Hours/week
- 0.3
-
James RosenJAMES ROSEN
CEO
- Total calculated
- $380,098
- From this org
- $366,650
- From related orgs
- $4,000
- Other
- $9,448
- Hours/week
- 40 + 0.5 related
Schedule J breakdown matched by us
- Base
- $366,650 + $4,000 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $9,448
- Filer's total
- $376,098 + $4,000 related
-
William Fletcher FaireyWILLIAM FLETCHER FAIREY
EXECUTIVE VP OF BUSINESS
- Total calculated
- $309,910
- From this org
- $285,352
- From related orgs
- $0
- Other
- $24,558
- Hours/week
- 40 + 0.5 related
Schedule J breakdown matched by us
- Base
- $285,352
- Bonus
- $0
- Other
- $0
- Deferred
- $15,110
- Nontaxable benefits
- $9,448
- Filer's total
- $309,910
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · HIGHER EDUCATION AND RESEARCH · NC
Directly controlled by STATE OF NORTH CAROLINA
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 6 March 2026
- IRS schema version
- 2024v5.5
- Source object
- 202630769349300903
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.